Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies

Merck aims to double production of its antiviral pill to treat Covid-19 in 2022, the Financial Times reported Tuesday, as countries around the world scramble to secure scarce supplies before it’s even been approved for use by regulators.